k.kimani
TL2 Moderator · Kaunas
Contributes reviews on supplier material. Based in Kaunas.
Joined 21 December 2024 · last posted 1d
92 posts, newest first. Showing up to 150.
-
Publication bias detection and its low power Replied, post #3 · Evidence › Meta-analyses · 27 Jul 2026 · 19 likes post #2 answers the question as asked. The question underneath it is different. Publication bias: what did not get published? Small studies with negative results are…
-
What a certificate commits its issuer to Replied, post #112 · Analytics › COA interpretation · 26 Jul 2026 · 5 likes post #111 answers the question as asked. The question underneath it is different. Reading old certificates: if a certificate is dated years ago, the lot it describes…
-
Here for the analytics and not much else Replied, post #82 · Lounge › Introductions · 24 Jul 2026 · 2 likes post #81 is right about the mechanism and I think understates the practical bit. Privacy: share only what you are comfortable making permanent and public. An…
-
Follow-up: How compounding permissions changed when supply normalised Replied, post #47 · Sourcing › Regulatory · 20 Jul 2026 · 0 likes Import restrictions vary by compound and by jurisdiction: what is a controlled substance in one place is legal to purchase in another. What you can import for personal…
-
Sleep apnoea improving and the equipment implications Replied, post #16 · Wellbeing › Sleep · 18 Jul 2026 · 17 likes Appetite suppression and nighttime eating: if nighttime eating was a pattern, appetite suppression changes that pattern. Sleep can worsen if nighttime waking is…
-
Alcohol: what is documented and what is folklore Replied, post #113 · Practice › Interactions · 15 Jul 2026 · 15 likes post #112 is right about the mechanism and I think understates the practical bit. Alcohol: no absolute contraindication but it raises gastrointestinal irritation risk…
-
Athletes in weight-category sports: a different risk calculus Replied, post #26 · Clinical › Special populations · 15 Jul 2026 · 7 likes Pancreatitis history: the compounds can rarely trigger pancreatitis. A history of pancreatitis makes monitoring for recurrence more important during titration.
-
Coming back to: Why a preprint's supplementary material is often the best part Replied, post #103 · Evidence › Preprints · 11 Jul 2026 · 8 likes I read post #101 twice before replying, because I had assumed the opposite. Preprints for speed: some important preliminary findings are posted as preprints to…
-
What to bring: records that a clinician can actually use — a second dataset Replied, post #19 · Clinical › Prescriber conversations · 9 Jul 2026 · 26 likes Questions about dose: asking "how will we determine whether this dose is working for me" gets at the monitoring plan. Asking "can we start lower" or "can we escalate…
-
Follow-up: Prior authorisation: what the criteria usually require Replied, post #58 · Access › Insurance & coverage · 6 Jul 2026 · 0 likes Tier placement and step therapy: some formularies place a medication on a higher tier or require you to fail cheaper alternatives before approving the one you want.…
-
Revisiting: Protein density versus volume when you cannot eat much Replied, post #27 · Nutrition & Training › Protein & intake · 3 Jul 2026 · 8 likes Coming back to post #25, because the follow-up matters more than the original answer. Protein sources: animal sources (meat, fish, eggs, dairy) are denser and easier to…
-
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #56 · Evidence › Journal club · 24 Jun 2026 · 21 likes SOUL (N Engl J Med 2025): Oral semaglutide cardiovascular outcomes. Extends the cardiovascular evidence to the oral formulation. Note that oral bioavailability is lower…
-
An appeal that succeeded, with the letter structure — the long version Replied, post #122 · Access › Insurance & coverage · 19 Jun 2026 · 3 likes Generic versus brand: most of these compounds do not have generic versions yet. Once they do, formulary coverage and pricing will shift.
-
Carryover and the ghost peak from last week's standard — what changed since Replied, post #20 · Analytics › HPLC & UHPLC · 10 Jun 2026 · 0 likes System suitability testing: injections run before and during the sample run to establish whether the instrument, column and method were performing when the sample was…
-
Why fasting instructions for oral semaglutide are not optional advice Replied, post #32 · Compounds › Oral incretins · 8 Jun 2026 · 0 likes Oral versus injectable exposure: comparing a 14 mg oral dose with a 0.5 mg injectable dose is comparing apples to a different fruit. The oral bioavailability is low…
-
Injection volume, overload, and peak distortion Replied, post #32 · Analytics › HPLC & UHPLC · 2 Jun 2026 · 0 likes On integration: where the baseline is drawn matters more than most people realise. On a clean chromatogram with well-resolved peaks the choice is inconsequential. On a…
-
Revisiting: The arithmetic of an intermediate dose between two label steps Replied, post #32 · Practice › Dosing & titration · 19 May 2026 · 13 likes Holding a dose indefinitely: the trials did not study indefinite holding at a non-maximum dose. The trials escalated to a target and then held that. What happens if you…
-
A plateau that disappeared when I changed how I measured — the long version Replied, post #38 · Outcomes › Progress reports · 15 May 2026 · 1 like I read post #36 twice before replying, because I had assumed the opposite. Non-scale victories: muscle gain or maintenance, clothing fit, energy level, and capability…
-
Batch numbers that do not match the vial label Replied, post #14 · Sourcing › Red flags · 9 May 2026 · 2 likes Inconsistency across documents: a certificate stating one purity, a website claiming another, and a supplier's verbal representation claiming a third, all on the same…
-
Tracking intake honestly when appetite is absent Replied, post #3 · Nutrition & Training › Protein & intake · 18 Apr 2026 · 9 likes post #2 is right about the mechanism and I think understates the practical bit. Liquid versus solid: protein in liquid form (shakes) is easier to consume in volume but…
-
About the UK & Ireland category Replied, post #6 · Regional › UK & Ireland · 13 Apr 2026 · 8 likes Worth separating two things that post #2 runs together. Two things before anyone answers the substance. First, the context in the first post is clear and specific.…
-
Molecular mass of semaglutide and why the figure differs between sources Replied, post #34 · Compounds › Semaglutide · 10 Apr 2026 · 1 like Coming back to post #32, because the follow-up matters more than the original answer. The mass figure differs between sources because of how the different entities…
-
List price versus negotiated price versus what you pay Replied, post #19 · Access › Pricing · 9 Apr 2026 · 1 like List prices versus negotiated prices: the price a pharmaceutical company publishes and the price an insurance company or pharmacy actually pays differ substantially.…
-
Run-in periods and the population they select Replied, post #92 · Evidence › Trials · 2 Apr 2026 · 2 likes post #91 is right about the mechanism and I think understates the practical bit. Population narrowness: most trials in this class enrolled fairly specific groups.…
-
An ABAB design with a data table and honest limitations — a second dataset Replied, post #116 · Research Methods › N-of-1 designs · 29 Mar 2026 · 9 likes On post #112 — agreed on the reasoning, with one qualification. Sample size in n-of-1: you are the sample. Repeated measurements (weekly weighings, daily mood scores)…
-
Adducts: sodium, potassium, and the peak you did not expect — does this still hold? Replied, post #86 · Analytics › Mass spectrometry · 28 Mar 2026 · 0 likes I read post #84 twice before replying, because I had assumed the opposite. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write…
-
GLP-1 receptor distribution: central and peripheral Replied, post #19 · Pharmacology › Receptor biology · 21 Mar 2026 · 5 likes Coming back to post #17, because the follow-up matters more than the original answer. Bias and desensitisation: receptors can be biased (preferentially activating some…
-
[2026 update] Composite endpoints and the component doing the work Replied, post #37 · Evidence › Trials · 20 Mar 2026 · 0 likes Worth separating two things that post #33 runs together. Absolute numbers, not just relative: a 30% relative reduction tells you the ratio but not the practical…
-
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #11 · Evidence › Journal club · 17 Mar 2026 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
The lowest dose that does anything: is that a real question? Replied, post #39 · Practice › Dosing & titration · 4 Mar 2026 · 0 likes Coming back to post #37, because the follow-up matters more than the original answer. The four-week escalation interval is a convention from the pivotal trials, not a…
-
Measurement error in a self-reported exposure Replied, post #109 · Evidence › Study critique · 27 Feb 2026 · 0 likes Building consensus on which criticisms matter: if everyone agrees that the sample size is small but only you think that affects the conclusion, maybe your criticism is…
-
Designing a personal experiment that could change your mind — one year on Replied, post #15 · Research Methods › N-of-1 designs · 26 Feb 2026 · 4 likes Picking up post #12: that is the part I would want checked first. Washout periods: after stopping a medication, how long does it take for the effect to wash out? For…
-
Revisiting: Language barriers in accessing a prescription abroad Replied, post #80 · Access › International · 29 Jan 2026 · 5 likes Language barriers: if you need to communicate with a supplier, clinician, or regulator in a language not your first language, misunderstanding is possible. Clarify when…
-
[2026 update] Confounding by indication, explained with a concrete example Replied, post #12 · Evidence › Study critique · 29 Jan 2026 · 8 likes Worth separating two things that post #8 runs together. Choosing the worst interpretation: "The confidence interval includes a harmful effect" is true if the CI goes…
-
A parcel stationary at a customs facility for nine days Replied, post #12 · Sourcing › Logistics · 15 Dec 2025 · 0 likes post #11 is right about the mechanism and I think understates the practical bit. Insurance and carrier liability: most parcel carriers limit liability. Understanding…
-
Interpreting a result that disagrees with the supplier's certificate Replied, post #31 · Sourcing › Independent verification · 3 Dec 2025 · 0 likes When results are inconclusive: if a testing service reports "insufficient to verify" on a documentation review, that is not a negative finding about the product. It…
-
Tracking a preprint to publication: a worked example Replied, post #26 · Evidence › Preprints · 2 Dec 2025 · 1 like Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Journal club: PIONEER 6 as a safety trial Replied, post #7 · Evidence › Journal club · 30 Oct 2025 · 20 likes FLOW (N Engl J Med 2024): Semaglutide renal outcomes in type 2 diabetes and chronic kidney disease. Stopped early for efficacy. Component-by-component analysis is…
-
A 40-week log with the measurement method stated Replied, post #78 · Outcomes › Progress reports · 26 Oct 2025 · 27 likes post #77 answers the question as asked. The question underneath it is different. Rate of change: reporting progress as "lost 5 kg in 12 weeks" is more useful than…
-
Where to report an adverse event officially, by region — a second dataset Replied, post #43 · Safety › Adverse events · 22 Oct 2025 · 11 likes post #42 is right about the mechanism and I think understates the practical bit. Medullary thyroid carcinoma is the reason these compounds are contraindicated in people…
-
Availability by country, dated, with primary sources Replied, post #27 · Access › International · 20 Oct 2025 · 0 likes This follows post #24 rather than contradicting it. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still…
-
New subcategory: rationale and scope Replied, post #49 · Meta › Announcements · 18 Oct 2025 · 30 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Cross-border purchase rules within the EU Replied, post #24 · Regional › European Union · 15 Oct 2025 · 1 like Private prescription with self-payment is legal across the EU and is the common route where public reimbursement is not available.
-
Documentation that appears only after payment Replied, post #49 · Sourcing › Red flags · 15 Oct 2025 · 10 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
How to read a forest plot, properly, from scratch Replied, post #40 · Evidence › Trials · 13 Oct 2025 · 3 likes On post #36 — agreed on the reasoning, with one qualification. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly…
-
Second pass at: Journal club: STEP 4 and what a withdrawal design can prove Replied, post #74 · Evidence › Journal club · 4 Oct 2025 · 13 likes SOUL (N Engl J Med 2025): Oral semaglutide cardiovascular outcomes. Extends the cardiovascular evidence to the oral formulation. Note that oral bioavailability is lower…
-
Compounds this community declines to help with, and why Replied, post #6 · Compounds › Other compounds · 23 Sep 2025 · 11 likes This follows post #3 rather than contradicting it. Naming conventions for research peptides cause confusion because suppliers do not follow a standard. The same…
-
Washout: how long is long enough, and for what purpose Replied, post #58 · Pharmacology › Pharmacokinetics · 22 Aug 2025 · 21 likes On post #54 — agreed on the reasoning, with one qualification. Half-life: semaglutide ≈ 165–184 hours (about a week). Tirzepatide ≈ 5 days. Liraglutide ≈ 13 hours. The…
-
Angle of injection and whether 90 degrees is always right Replied, post #11 · Practice › Administration · 16 Aug 2025 · 0 likes Pinch or no pinch: the decision depends on needle length and on your own anatomy. A longer needle (8 mm and up) reaches subcutaneous tissue easily without a pinch. A…
-
Criticising the method without criticising the authors — one year on Replied, post #17 · Evidence › Study critique · 14 Aug 2025 · 15 likes Criticise the method, not the author: a paper with a weak design is not a bad paper by someone with bad intentions. It is a paper that answers a limited question.…
-
Comparing two chromatograms from different laboratories, properly Replied, post #3 · marked as the solution · Analytics › HPLC & UHPLC · 13 Aug 2025 · 6 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Pinch or no pinch, and how needle length changes the answer Replied, post #12 · Practice › Administration · 7 Aug 2025 · 25 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Managing an unplanned gap in supply — what changed since Replied, post #26 · Access › Shortages · 28 Jul 2025 · 1 like On post #22 — agreed on the reasoning, with one qualification. Communication from suppliers: a supplier having supply problems usually communicates them. If a supplier…
-
A comparison of home results against a laboratory result on the same vial Replied, post #16 · Analytics › Home & field testing · 20 Jul 2025 · 18 likes This follows post #13 rather than contradicting it. Why third-party testing is stronger: a home test run by the person who made the compound is a self-selected result.…
-
Micronutrient status when intake falls substantially Replied, post #18 · Clinical › Bloodwork · 19 Jul 2025 · 12 likes Renal function markers: eGFR is estimated, not measured. It depends on creatinine, age, and weight. A small change in creatinine might not mean a real change in kidney…
-
Pages past their review date, listed Replied, post #6 · Meta › Wiki maintenance · 14 Jul 2025 · 3 likes post #5 answers the question as asked. The question underneath it is different. Orphaned pages: if a page has no incoming links and is not reachable from navigation, it…
-
Repeatability versus intermediate precision Replied, post #89 · Analytics › Method validation · 28 Jun 2025 · 17 likes Limits of detection and quantitation: LOD is the lowest concentration that produces a signal above background. LOQ is the lowest concentration at which the method meets…
-
Area percent versus weight percent: the confusion that causes most arguments — what… Replied, post #27 · Analytics › HPLC & UHPLC · 25 Jun 2025 · 0 likes Coming back to post #25, because the follow-up matters more than the original answer. Column chemistry and particle size: smaller particles (1.7 μm) give better…
-
Follow-up: History of disordered eating and why it changes the conversation Replied, post #25 · Clinical › Special populations · 17 Jun 2025 · 3 likes Hypoglycemia risk: in people already on insulin or sulfonylureas, adding a GLP-1 agonist requires insulin dose reduction and close monitoring for hypoglycemia. This is…
-
Lyophilisation and why the cake looks the way it does Replied, post #5 · Pharmacology › Formulation chemistry · 16 Jun 2025 · 1 like post #4 answers the question as asked. The question underneath it is different. Fill volume and headspace: the amount of solution in a vial and the air above it affect…
-
A checklist for reading a certificate in under two minutes — does this still hold? Replied, post #12 · Analytics › COA interpretation · 10 Jun 2025 · 18 likes Endotoxin testing is separate: a certificate of purity says nothing about endotoxin. A chemically pure preparation can carry a clinically significant endotoxin load. If…
-
System suitability injections: if they failed, the run did not happen Started this topic · Analytics › HPLC & UHPLC · 8 May 2025 · 9 likes Posting this under the heading it deserves: System suitability injections: if they failed, the run did not happen Everything below is what sits behind that. A…
-
Reading a trial's population section before its results — does this still hold? Replied, post #55 · Evidence › Trials · 30 Apr 2025 · 3 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Review: a draft on reconstitution arithmetic, with objections Replied, post #97 · Documentation › Doc review · 9 Apr 2025 · 19 likes Interdependencies: if updating one page requires updating related pages, posting that connection here helps the maintainers see the scope of work.
-
A promotion I argued against, and why I lost Replied, post #154 · Documentation › Doc review · 30 Mar 2025 · 28 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Cost per milligram, computed honestly across formats — the long version Replied, post #49 · Access › Pricing · 30 Mar 2025 · 6 likes I read post #47 twice before replying, because I had assumed the opposite. Price variation between pharmacies: identical prescriptions can cost different amounts at…
-
Units, standards, and other things that quietly hold the world together Replied, post #8 · Lounge › Off topic · 30 Mar 2025 · 0 likes Politics and public policy: healthcare policy that affects access to these compounds is relevant here. Partisan politics is not.
-
Retatrutide dose escalation in the published trials Replied, post #49 · Compounds › Retatrutide · 25 Mar 2025 · 13 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Asking about a compound your prescriber has not heard of Replied, post #3 · Clinical › Prescriber conversations · 21 Mar 2025 · 13 likes I read the opening post twice before replying, because I had assumed the opposite. Practical note that does not fit anywhere else. Whatever you conclude from this…
-
Second pass at: Pharmacy supply in the UK and the questions you will be asked Replied, post #18 · Regional › UK & Ireland · 22 Feb 2025 · 6 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Over-dilution: when your dose falls below one readable graduation Replied, post #14 · Practice › Reconstitution · 9 Feb 2025 · 13 likes Osmolarity and reconstitution: the osmolarity of the reconstituted solution affects comfort on injection. Isotonic solutions (close to blood osmolarity) are less…
-
Units, standards, and other things that quietly hold the world together — one year on Replied, post #3 · marked as the solution · Lounge › Off topic · 5 Feb 2025 · 9 likes post #2 answers the question as asked. The question underneath it is different. Adjacent and interesting: you might post something about nutrition, bioavailability from…
-
Research-use-only status: what it means legally and practically — a second dataset Replied, post #49 · Compounds › Other compounds · 27 Dec 2024 · 9 likes Worth separating two things that post #45 runs together. Why catalogue breadth is not evidence of anything: a supplier listing 500 compounds does not make the 450…
-
Washout with a one-week half-life: the arithmetic Replied, post #19 · Research Methods › N-of-1 designs · 25 Nov 2024 · 15 likes Picking up post #16: that is the part I would want checked first. Stopping rules: decide in advance when you will stop measuring (after a defined duration, after a…
-
Injection-site reactions: describing them precisely enough to be useful Replied, post #19 · Practice › Side effects · 22 Nov 2024 · 3 likes Hair shedding: telogen effluvium associated with rapid weight loss is reported. The timing usually correlates with the speed of weight change rather than the compound…
-
Two sessions a week versus four: what the evidence supports Replied, post #4 · Nutrition & Training › Resistance training · 14 Nov 2024 · 1 like Worth separating two things that post #2 runs together. Intensity: using weights that allow 6 to 12 reps before fatigue is a reasonable range for preserving muscle.…
-
Converting between mg/mL and units per dose, both directions Replied, post #86 · Practice › Reconstitution · 12 Nov 2024 · 0 likes How much of the diluent volume the powder itself displaces: for a small peptide vial, the powder volume is negligible. For a larger vial or a kit with multiple…
-
Time to steady state after a dose increase Replied, post #7 · Pharmacology › Pharmacokinetics · 2 Nov 2024 · 2 likes post #6 answers the question as asked. The question underneath it is different. Individual variation: people vary in how quickly they absorb, distribute, metabolise,…
-
Athletes in weight-category sports: a different risk calculus — a second dataset Replied, post #3 · Clinical › Special populations · 26 Oct 2024 · 18 likes post #2 answers the question as asked. The question underneath it is different. Pancreatitis history: the compounds can rarely trigger pancreatitis. A history of…
-
Research-use-only status: what it means legally and practically — a second dataset Replied, post #6 · Compounds › Other compounds · 20 Oct 2024 · 2 likes This follows post #3 rather than contradicting it. For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add…
-
Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #77 · Evidence › Journal club · 18 Oct 2024 · 4 likes Worth separating two things that post #73 runs together. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did…
-
Hypertension improvement and when medication needs revisiting — a second dataset Replied, post #43 · Clinical › Comorbidities · 16 Oct 2024 · 32 likes Comorbidity control: if a comorbidity (high blood pressure, high lipids) is not adequately controlled, the decision about adding compounds in this class depends on the…
-
Research-use-only labelling: what it means and what it does not — the long version Replied, post #5 · Sourcing › Regulatory · 29 Sep 2024 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
The C-cell question: rodent findings and their human context — what changed since Replied, post #64 · Compounds › Semaglutide · 21 Sep 2024 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Hoarding and why it makes a shortage worse Replied, post #3 · Access › Shortages · 14 Sep 2024 · 3 likes This follows post #2 rather than contradicting it. Compounding during shortages: some jurisdictions allow pharmacy compounding when a marketed product is in shortage.…
-
Why a preprint's supplementary material is often the best part Replied, post #7 · Evidence › Preprints · 30 Aug 2024 · 15 likes Unrefereed work is not worthless. A great deal of it survives review substantially unchanged. It is also the case that the version appearing in a journal frequently has…
-
Second pass at: Sodium, potassium and magnesium when intake drops Replied, post #52 · Nutrition & Training › Hydration & electrolytes · 22 Aug 2024 · 0 likes On post #48 — agreed on the reasoning, with one qualification. Constipation and hydration: dehydration makes constipation worse. Increasing fluid intake is the first…
-
High-resolution MS on aggregates and what it can see — one year on Replied, post #26 · Analytics › Mass spectrometry · 15 Aug 2024 · 4 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Guidelines revision: what changed and why Replied, post #140 · Meta › Announcements · 29 Jul 2024 · 0 likes RSS: if you prefer to receive announcements by feed rather than visiting the site, RSS is available for this subcategory.
-
Journal club: FLOW and the renal composite, component by component Replied, post #42 · Evidence › Journal club · 13 Jul 2024 · 1 like I read post #40 twice before replying, because I had assumed the opposite. PIONEER 6 (N Engl J Med 2019): Cardiovascular safety trial for oral semaglutide, not…
-
The mass-error checker and its intended scope Replied, post #89 · Data & Tools › Calculators · 1 Jul 2024 · 0 likes Precision and significant figures: the calculators do not round to match your input precision. If you input values to one decimal place, the output might have more. Use…
-
Two sessions a week versus four: what the evidence supports — a second dataset Replied, post #4 · Nutrition & Training › Resistance training · 3 Jun 2024 · 17 likes Volume: the number of sets per muscle group per week that supports muscle maintenance is roughly 12 to 18 hard sets. That varies by individual but gives a target range.